Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Terminated 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Gastrointestinal 1

Conditions

Weight Loss 1Pancreatic Neoplasms 1Lung Neoplasms 1Liver Neoplasms 1Carcinoma, Hepatocellular 1Cachexia 1Body Weight 1Anorexia 1

Interventions

Octreotide 3remune 1irinotecan sucrosofate 1bermekimab 1anamorelin 1Urine Specimen Collection 1Psychology, Positive 1Olanzapine 1Methods 1Melatonin 1Megestrol Acetate 1Fluorouracil 1Exercise 1Enteral Nutrition 1Endoscopy, Digestive System 1Diet Therapy 1Diet 1Caloric Restriction 1Blood Specimen Collection 1Biopsy 1Acetylcysteine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Weight Loss × Megestrol Acetate × Gastrointestinal × Clear all
NCT00637728 2016-06-23

Treatment of Cancer-anorexia Using Megestrol Acetate Concentrated Suspension in Lung or Pancreatic Cancer Patients

Par Pharmaceutical, Inc.

Phase 3 Terminated
5 enrolled 8 charts
GastrointestinalThoracic

Anorexia, Body Weight, Cachexia, Lung Neoplasms, Pancreatic Neoplasms, Weight Loss

Data powered by HemOnc (CC BY 4.0) Colophon âš¡